Regulation And Legal
Prism Medico No NCS Payable Q1 FY27
Prism Medico and Pharmacy Ltd filed an intimation under SEBI LODR Regulation 57(4) with BSE and MSEI.
The company confirms no non-convertible securities with interest/dividend/principal due in Q1 FY27
